Fintel reports that on November 15, 2024, Ladenburg Thalmann downgraded their outlook for Bionano Genomics (NasdaqCM:BNGO) ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good day, and welcome to the Bionano Third Quarter 2024 Earnings ...

Bionano Genomics ( (BNGO) ) has released its Q3 earnings. Here is a breakdown of the information Bionano Genomics presented to its investors.

Based on offerings, the genomics market is divided into product and service segments. The product segment accounted for the ...

In a report released today, Sung Ji Nam from Scotiabank maintained a Hold rating on BioNano Genomics (BNGO – Research Report), with a ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.28% ...

Bionano expects to file its Form 10-Q no later than 5.30 p.m. The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Bionano ...

The International Forum on the Diagnosis and Treatment of Rare Diseases was held on October 30th to 31st in Tashkent. The ...

Genomics England and Cancer52 have collaborated throughout the year culminating in a recent roundtable with Cancer52’s ...

Exercise is important, but reducing sitting time is key to cutting down on the risks that come with sedentary behavior. A ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management ...